Apoplexy

IBSA Group and Granata Bio announces first patient screened in pivotal PROGRESS clinical trial of Progesterone-IBSA

Retrieved on: 
Wednesday, October 19, 2022
Reproductive health, Disease, Centers for Disease Control and Prevention timeline, Woman, Vaginal bleeding, Blastocyst, Luteal phase, Progesterone, Patient, ART, Malignancy, Multimedia, IBSA, Transfer, Rest, Plasma protein binding, III, Marketing, Health, CEO, PROGRESS, Breast, Ageing, Safety, Clinical trial, Infertility, Liver, Center, Pregnancy, Thrombophlebitis, Apoplexy, Prevention, Pharmaceutical industry, Birth control

BOSTON, Oct. 20, 2022 /PRNewswire/ -- IBSA Group and Granata Bio today announced the screening of the first patient in the pivotal phase III PROGRESS (PROGesterone fRozenEuploid blaStocyst tranSfer) clinical trial (Clinical Trials.gov Identifier: NCT04549116).

Key Points: 
  • BOSTON, Oct. 20, 2022 /PRNewswire/ -- IBSA Group and Granata Bio today announced the screening of the first patient in the pivotal phase III PROGRESS (PROGesterone fRozenEuploid blaStocyst tranSfer) clinical trial (Clinical Trials.gov Identifier: NCT04549116).
  • The study is expected to enroll about 680 patients between the ages of 35-42 years old.
  • "The IBSA Group is excited for this key milestone in development of our subcutaneous progesterone in the United States.
  • IBSA Group, headquartered in Lugano, Switzerland, is a leader in reproductive health and has a diversified product portfolio of prescription drugs and biologics.

The Worldwide Recombinant Proteins Industry is Expected to Reach $5 Billion by 2030 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, September 21, 2022
Biotechnology, Genetics, Health, American Cancer Society, Therapy, Multiple sclerosis, Incidence, COVID-19, D, Prevalence, Biomedical Research, A-DNA, ELISA, Lists of diseases, Apoplexy, Dwarfism, Industry, IHC, Degenerative disease, Patient, Cancer, Neutropenia, Research, Conditional sentence, Anemia, CAGR, Vaccine, Fine chemical, Immunohistochemistry

Furthermore, the industry is anticipated to expand due to the increased development and research on biologics, which, in turn, are significantly boosting global industry growth.

Key Points: 
  • Furthermore, the industry is anticipated to expand due to the increased development and research on biologics, which, in turn, are significantly boosting global industry growth.
  • The focus on the development of biosimilars, biologics, and recombinant proteins has increased owing to a rise in the incidence and prevalence of cancer and the expansion of research & development activity.
  • According to the American Cancer Society, in 2022, there will be 1.9 million new cases of cancer and 609,360 cancer-related deaths.
  • In addition, the expanding application of recombinant proteins in clinical diagnostic methods including ELISA, Western Blotting, and Immunohistochemistry (IHC) is anticipated to fuel market expansion.

WIMI Hologram Academy: The application of virtual reality technology in balance function disorder after cerebral apoplexy

Retrieved on: 
Wednesday, April 27, 2022
Cloud, Statistics, Computer, Injury, Feedback, Disability, CVA, Stroke, NASDAQ, Research, Work, Rehabilitation, Science, Posture, GLOBE, Subarachnoid hemorrhage, Patient, Berg Balance Scale, Muscle, VR, WIMI, Walking, Cerebral infarction, Technology, Movement, Proprioception, Ischemia, Method, Maintenance, Falls, AI, Intracranial hemorrhage, Apoplexy, Hemiparesis, Partnership, Risk, Neurophysiology, Nature, Pharmaceutical industry, Medical imaging

Typically it includes cerebral hemorrhage, cerebral infarction, subarachnoid hemorrhage and other diseases.Scientists from WIMI Hologram Academy of WIMI Hologram Cloud Inc. (NASDAQ: WIMI) have studied the application of virtual reality technology in balance function disorder after cerebral apoplexy.

Key Points: 
  • Typically it includes cerebral hemorrhage, cerebral infarction, subarachnoid hemorrhage and other diseases.Scientists from WIMI Hologram Academy of WIMI Hologram Cloud Inc. (NASDAQ: WIMI) have studied the application of virtual reality technology in balance function disorder after cerebral apoplexy.
  • Virtual reality technology uses a computer to simulate the real world and allows the user to experience the virtual world.
  • Virtual reality technology uses computers to synthesize 3D environment models and apply these models to create and experience virtual worlds.
  • The study indicated that by combining virtual reality rehabilitation exercises with conventional rehabilitation training, patientslimb function, neurological function, balance function, as well as their life quality can be effectively improved.